Based on logistic regression, the study by Armstrong et al. in 2000 found that the presence of a family history of breast and ovarian cancer, Jewish ancestry, perceived risk of breast and ovarian cancer, and fear of detection of preventive and curative intervention by the insurance system was associated with the decision to test for BRCA1/2. This evidence concerns the gene BRCA1 and medical procedure.